Changing Patterns of Causation and the Use of Transplantation in the United Kingdom

 

 Buy Article Permissions and Reprints

ABSTRACT

Acute liver failure (ALF) is a rare condition in the United Kingdom. Comprehensive supportive intensive care of extra-hepatic organ failure and the early recognition of and use of transplantation for those who will not survive form the cornerstone of its management. Over the last 30 years there has been a reduction in the proportion of cases resulting from viral and seronegative hepatitis, and a progressive rise in those resulting from severe acetaminophen-induced hepatotoxicity. The latter cases mostly result from deliberate self-poisoning and formed the major cause of ALF hospital admissions and indication for emergency liver transplantation. The increasing misuse of acetaminophen has paralleled a rise in sales and greater availability of the drug. Introduction of legislation to restrict sales of acetaminophen has been followed by a fall in hospital admissions resulting from self-poisoning, a 20% reduction in deaths, and a 50% fall in the number of patients undergoing emergency liver transplantation. The reduction in acetaminophen-related ALF has been paralleled by an increase in the number of transplants performed in ALF of nonacetaminophen etiologies.

REFERENCES

• 1 Mortality Statistics: cause.  National Statistics. London: The Stationery Office; 1999
  Google Scholar
• 2 Williams R. Classification, etiology, and considerations of outcome in acute liver failure.  Semin Liver Dis . 1996;  16 343-348
  Article in Thieme ConnectPubMedGoogle Scholar
• 3 O'Grady J. Acute liver failure. In: O'Grady J, Lake J, Howdle P, eds. Comprehensive Clinical Hepatology, 1st ed London: Mosby 2000 : 30.1-30.20
  Google Scholar
• 4 Hartley P, Petruckvitch A, Reeves B. et al . The national liver transplantation audit: an overview of patients presenting for liver transplantation from 1994 to 1998.  Br J Surg . 2001;  88 52-58
  CrossrefPubMedGoogle Scholar
• 5 Statistics prepared by UK Transplant from the National Transplant Database maintained on behalf of transplant services in the UK and Republic of Ireland. October 2002
  Google Scholar
• 6 Dhiman R, Seth A, Jain S. et al . Prognostic evaluation of early indicators in fulminat hepatic failure by multivariate analysis.  Dig Dis Sci . 1998;  43 1311-1316
  CrossrefPubMedGoogle Scholar
• 7 Ellis A, Rhodes A, Jackson N. et al . Acute liver failure (ALF) in a specialist intensive care unit; a 7 year experience.  Crit Care . 1998;  2(Suppl 1) P150
  PubMedGoogle Scholar
• 8 Ostapowicz G, Fontana R, Sciodt F. et al . Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.  Ann Intern Med . 2002;  137 947-954
  CrossrefPubMedGoogle Scholar
• 9 Trigo P, Lendoire J, Braslavsky G. et al . Etiology and outcome of 83 patients with fulminant hepatic failure in adults. Experience of an Argentinian liver transplant unit.  Hepatology . 2001;  34 657A
  PubMedGoogle Scholar
• 10 O'Grady J, Schalm S, Williams R. Acute liver failure; redefining the syndromes.  Lancet . 1993;  342 273-275
  CrossrefPubMedGoogle Scholar
• 11 O'Grady J, Alexander G, Hayllar K, Williams R. Early indicators of prognosis in fulminant hepatic failure.  Gastroenterology . 1989;  97 439-445
  PubMedGoogle Scholar
• 12 Anand A, Nightingale P, Neuberger J. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Kings's criteria.  J Hepatol . 1997;  26 62-68
  CrossrefPubMedGoogle Scholar
• 13 Bernal W, Wendon J, Rela M. et al . Use and outcome of liver transplantation in acetaminophen induced acute liver failure.  Hepatology . 1998;  27 1050-1055
  CrossrefPubMedGoogle Scholar
• 14 O'Grady J, Wendon J, Tan K. et al . Liver transplantation after paracetomol overdose.  BMJ . 1991;  303 221-223
  PubMedGoogle Scholar
• 15 Mitchell I, Bihari D, Chang R. et al . Earlier identification of patients at risk from acetaminophen induced acute liver failure.  Crit Care Med . 1998;  26 279-284
  PubMedGoogle Scholar
• 16 Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure.  Lancet . 2002;  359 558-563
  CrossrefPubMedGoogle Scholar
• 17 Pereira L M, Langley P G, Hayllar K M. et al . Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators.  Gut . 1992;  33 98-102
  PubMedGoogle Scholar
• 18 Izumi S, Langley P G, Wendon J. et al . Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure.  Hepatology . 1996;  23 1507-1511
  CrossrefPubMedGoogle Scholar
• 19 Sizer E, Bernal W, Wendon J. Acute liver failure in the intensive care unit. In: Vincent J, ed. 2003 Yearbook of Intensive Care and Emergency Medicine Berlin: Springer 2003
  Google Scholar
• 20 Rivers E, Nguyen B, Havstad S. et al . Goal-directed therapy for severe sepsis and septic shock.  N Engl J Med . 2001;  345 1368-1377
  CrossrefPubMedGoogle Scholar
• 21 Makin A, Wendon J, Williams R. A seven year experience of severe acetominophen-induced hepatotoxicity (1987-1993).  Gastroenterology . 1995;  109 1907-1916
  CrossrefPubMedGoogle Scholar
• 22 Bihari D, Gimson A, Lindridge J, Williams R. Lactic acidosis in fulminant hepatic failure: some aspects of pathogenesis and prognosis.  J Hepatol . 1985;  1 405-416
  PubMedGoogle Scholar
• 23 Harry R, Ausinger G, Wendon J. Clinical importance of adrenal insufficiency in acute hepatic dysfunction.  Hepatology . 2002;  36 395-402
  CrossrefPubMedGoogle Scholar
• 24 Annane D, Sebille V, Charpentier C. et al . Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.  JAMA . 2002;  288 862-871
  CrossrefPubMedGoogle Scholar
• 25 Davenport A, Will E J, Davidson A M. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure.  Crit Care Med . 1993;  21 328-338
  CrossrefPubMedGoogle Scholar
• 26 Davenport A, Will E J, Davison A M. et al . Changes in intracranial pressure during haemofiltration in oliguric patients with grade IV hepatic encephalopathy.  Nephron . 1989;  53 142-146
  PubMedGoogle Scholar
• 27 Forni L, Hilton P. Current concepts: continuous hemofiltration in the treatment of acute renal failure.  N Engl J Med . 1997;  336 1303-1309
  CrossrefPubMedGoogle Scholar
• 28 Bellomo R, Baldwin I, Ronco C. High volume hemofiltration.  Curr Opin Crit Care . 2000;  6 442-445
  PubMedGoogle Scholar
• 29 Ronco C, Bellomo R, Homel P. et al . Effects of different doses in continuous veno-venous hemofiltration on outcomes of acute renal failure: a prospective randomised trial.  Lancet . 2000;  355 26-30
  PubMedGoogle Scholar
• 30 Ede R, Gimson A, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral odema in fulminant hepatic failure.  J Hepatol . 1986;  2 43-51
  CrossrefPubMedGoogle Scholar
• 31 Wendon J A, Harrison P M, Keays R, Williams R. Cerebral blood flow and metabolism in fulminant liver failure.  Hepatology . 1994;  19 1407-1413
  CrossrefPubMedGoogle Scholar
• 32 Strauss G, Hogh P, Knudsen G. et al . Regional cerebral blood flow during mechanical hyperventilation in patients with fulminant hepatic failure.  Hepatology . 1999;  30 1368-1373
  CrossrefPubMedGoogle Scholar
• 33 Cordoba J, Gottstein J, Blei A. Chronic hyponatraemia exacerbates ammonia induced brain edema in rats after portocaval anastamosis.  J Hepatol . 1998;  29 589-594
  CrossrefPubMedGoogle Scholar
• 34 Murphy N, Wendon J. Serum sodium is inversely proportional to intracranial pressure in acute liver failure (Abst).  Crit Care . 1999;  3(Suppl 1) 110
  PubMedGoogle Scholar
• 35 Schell R, Cole D. Cerebral monitoring: jugular venous oximetry.  Anesth Analg . 2000;  90 559-566
  PubMedGoogle Scholar
• 36 Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infections in acute liver failure.  Semin Liver Dis . 1996;  16 389-402
  Article in Thieme ConnectPubMedGoogle Scholar
• 37 Rolando N, Wade J, Davalos M. et al . The systemic inflammatory response in acute liver failure.  Hepatology . 2000;  32 734-739
  CrossrefPubMedGoogle Scholar
• 38 O'Grady J. Fulminant hepatitis in patients with chronic liver disease.  J Viral Hepat . 2000;  7(Suppl 1) 9-10
  CrossrefPubMedGoogle Scholar
• 39 Sallie R, Silva A E, Purdy M. et al . Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serological study.  J Hepatol . 1994;  20 580-588
  CrossrefPubMedGoogle Scholar
• 40 Jackson N, Ellis A, Rhodes A. et al . Non-paracetamol drug induced acute liver failure in a specialist liver intensive care unit: a seven year experience.  Hepatology . 1998;  28 496A
  PubMedGoogle Scholar
• 41 Henry J A, Jeffreys K J, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy”).  Lancet . 1992;  340 384-387
  CrossrefPubMedGoogle Scholar
• 42 Ellis A J, Wendon J A, Portmann B, Williams R. Acute liver damage and ecstasy ingestion.  Gut . 1996;  38 454-458
  PubMedGoogle Scholar
• 43 Andreu V, Mas A, Bruguera M. et al . Ecstacy: a common cause of severe acute hepatotoxicity.  J Hepatol . 1998;  29 394-397
  PubMedGoogle Scholar
• 44 Crowcroft N, Walsh B, Davidson K. et al . Guidelines for the control of hepatitis A infection.  Communicable Disease and Public Health . 2001;  4 213-227
  PubMedGoogle Scholar
• 45 Goldberg D, McMenamin J. The United Kingdom's hepatitis B immunisation strategy-where now?.  Communicable Disease and Public Health . 1998;  1 79-83
  PubMedGoogle Scholar
• 46 Melnick J. History and epidemiology of hepatitis A virus.  J Infect Dis . 1995;  171(Suppl 1) S2-S8
  PubMedGoogle Scholar
• 47 Damme P V, Tormans G, Beutels P, Doorslaer E V. Hepatitis B prevention in Europe: a preliminary economic evaluation.  Vaccine . 1995;  13 S54-S57
  PubMedGoogle Scholar
• 48 Kyrlagkitsis I, Cramp M, Smith H. et al . Acute hepatitis A virus infection: a review of prognostic factors from 25 years experience in a tertiary referral center.  Hepatogastroenterology . 2002;  49 524-528
  PubMedGoogle Scholar
• 49 Gow P, Mutimer D. Non-A, non-B fulminant hepatic failure.  Arch Intern Med . 2001;  161 1013-1014
  CrossrefPubMedGoogle Scholar
• 50 Williams R, Riordan S. Acute liver failure: established and putatative hepatitis viruses and therapeutic implications.  J Gastroenterol Hepatol . 2000;  15 G17-G25
  CrossrefPubMedGoogle Scholar
• 51 McCrudden R, O'Connell S, Farrant T. et al . Sporadic acute hepatitis E in the United Kingdom: an underdiagnosed phenomenon?.  Gut . 2000;  46 732-733
  CrossrefPubMedGoogle Scholar
• 52 Wilkinson S, Taylor G, Templeton L. et al . Admissions to hospital for deliberate self-harm in England 1995-2000; an analysis of Hospital Episode Statistics.  J Public Health Med . 2002;  24 179-183
  PubMedGoogle Scholar
• 53 Hawton K, Fagg J, Simkin S. et al . Trends in deliberate self harm in oxford, 1985-1995.  Br J Psychiatry . 1997;  171 556-560
  PubMedGoogle Scholar
• 54 Shah R, Uren Z, Baker A, Majeed A. Trends in suicide from drug overdose in the elderly in England and Wales 1993-1999.  Int J Geriatr Psychiatry . 2002;  17 416-421
  PubMedGoogle Scholar
• 55 McLoone P, Crombie I K. Hospitalisation for deliberate self-poisoning in Scotland from 1981 to 1993; trends in rates and types of drugs used.  Br J Psychiatry . 1996;  169 81-85
  PubMedGoogle Scholar
• 56 Prescott L. Paracetamol overdose. In: Paracetamol (Acetaminophen) a Critical Bibliographic Review London: Taylor and Francis 1996: 401-473
  Google Scholar
• 57 Makin A J, Williams R. Acetaminophen-induced hepatotoxicity: predisposing factors and treatments.  Adv Intern Med . 1997;  42 453-483
  PubMedGoogle Scholar
• 58 Deaths related to drug poisoning results for England and Wales, 1993 to 2000. Health Statistic Quarterly 2002; 13:76-82 www.statistics.gov.uk/downloads/theme health/ HSQ13 v4.pdf . 
  Google Scholar
• 59 Makin A, Williams R. Paracetamol hepatotoxicity and alcohol consumption in deliberate and accidental overdose.  QJM . 2000;  93 341-349
  CrossrefPubMedGoogle Scholar
• 60 Townsend E, Hawton K, Harriss L. et al . Substances used in deliberate self poisoning 1985-1997; trend and associations with age, gender, repetition and suicidal intent.  Soc Psychiatry Psychiatric Epidemiol . 2001;  36 228-234
  CrossrefPubMedGoogle Scholar
• 61 Gunnell D, Hawton K, Murray V. et al . Use of paracetamol for suicide and non-fatal self poisoning in the UK and France: are restrictions on availability justified?.  J Epidemiol Community Health . 1997;  51 175-179
  CrossrefPubMedGoogle Scholar
• 62 Hawton K, Ware C, Mistry H. et al . Why patients choose paracetamol for self poisoning and their knowledge of its dangers.  BMJ . 1995;  310 69-73
  PubMedGoogle Scholar
• 63 Hawton K, Ware C, Mistry H. et al . Paracetamol self-poisoning. Characteristics, prevention and harm reduction.  Br J Psychiatry . 1996;  168 43-48
  PubMedGoogle Scholar
• 64 Newson P, Bathgate A, Henderson N. et al . Referral patterns and social deprivation in paracetamol-induced liver injury in Scotland.  Lancet . 2001;  358 1612-1613
  CrossrefPubMedGoogle Scholar
• 65 Hawton K, Harriss L, Hodder K. et al . The influence of economic and social environment on deliberate self-harm and suicide: an ecological and person-based study.  Psychol Med . 2001;  31 827-836
  CrossrefPubMedGoogle Scholar
• 66 Neeleman J, Wessely S. Drugs taken in fatal and non-fatal self poisoning a study in south London.  Acta Psychiatr Scand . 1997;  95 283-287
  PubMedGoogle Scholar
• 67 Prescott L. Paracetamol, alcohol and the liver.  Br J Clin Pharmacol . 2000;  49 291-301
  CrossrefPubMedGoogle Scholar
• 68 Schmidt L, Dalhoff K, Poulsen H. Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity.  Hepatology . 2002;  35 876-882
  CrossrefPubMedGoogle Scholar
• 69 Kuffner E, Dart R, Bogdan G. et al . Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients.  Arch Intern Med . 2001;  161 2247-2252
  CrossrefPubMedGoogle Scholar
• 70 Whitcomb D, Block G. Association of acetaminophen hepatotoxicity with fasting and ethanol use.  JAMA . 1994;  272 1845-1850
  CrossrefPubMedGoogle Scholar
• 71 Read R B, Tredger J M, Williams R. Analysis of factors responsible for continuing mortality after paracetamol overdose.  Hum Toxicol . 1986;  5 201-206
  PubMedGoogle Scholar
• 72 Foster T. Dying for a drink.  BMJ . 2001;  323 817-818
  CrossrefPubMedGoogle Scholar
• 73 Galanos A, Pieper C, Kussin P. et al . Relationship of body mass index to subsequent mortality among seriously ill hospitalised patients.  Crit Care Med . 1997;  25 1962-1968
  PubMedGoogle Scholar
• 74 Sheen C, Dillon J, Bateman D. et al . Paracetamol toxicity: epidemiology, prevention and costs to the health-care system.  QJM . 2002;  95 609-619
  CrossrefPubMedGoogle Scholar
• 75 Jones A, Hayes P, Proudfoot A. et al . Should methionine be added to every paracetamol tablet?.  BMJ . 1997;  315 301-304
  PubMedGoogle Scholar
• 76 Gunnell D, Murray V, Hawton K. Use of paracetamol (acetaminophen) for suicide and nonfatal poisoning: worldwide patterns of use and misuse.  Suicide Life Threat Behav . 2000;  30 313-326
  PubMedGoogle Scholar
• 77 WHO. The world health report 2001. Mental health: new understanding, new hope. Geneva: World Health Organization 2001
  Google Scholar
• 78 Proudfoot A T, Park J. Changing pattern of drugs used for self-poisoning.  BMJ . 1978;  1 90-93
  PubMedGoogle Scholar
• 79 Bowles J. Suicide prevention in western Samoa: an example of a suicide prevention program in a developing country. In: Diekstra R, Gulbinat W, Kienhorst I, Leo D, eds. Preventative Strategies on Suicide Leiden: EJ Brill 1995: 173-206
  Google Scholar
• 80 Oliver R, Hetzel B. An analysis of recent trends in suicide rates in Australia.  Int J Epidemiol . 1973;  2 91-101
  PubMedGoogle Scholar
• 81 Ott P, Dalhoff K, Hansen P B. et al . Consumption, overdose and death from analgesics during a period of over-the-counter availability of paracetamol in Denmark.  J Int Med . 1990;  227 423-428
  CrossrefPubMedGoogle Scholar
• 82 Committee on Safety of Medicines, Medicines Control Agency. Paracetamol and aspirin.  Current Problems in Pharmacovigilance . 1997;  23 9
  PubMedGoogle Scholar
• 83 Fagan E, Wannan G. Reducing paracetomol overdoses.  BMJ . 1996;  313 1417-1418
  PubMedGoogle Scholar
• 84 Laffoy M, Byrne G, Scallan E. Paracetamol availability and overdose in Ireland.  Irish Med J . 2001;  94 7
  PubMedGoogle Scholar
• 85 Thomas M, Jowett N. Restriction has not reduced admissions with self poisoning.  BMJ . 2001;  322 553
  CrossrefPubMedGoogle Scholar
• 86 Balit C, Isbister G, Peat J. et al . Paracetamol recall: a natural experiment influencing analgesic poisoning.  Med J Aust . 2002;  176 163-166
  PubMedGoogle Scholar
• 87 Hawton K, Townsend E, Deeks J. et al . Effects of legislation restricting pack sizes of paracetamol and salycilate poisoning in the United Kingdom; before and after study.  BMJ . 2001;  322 1203-1207
  CrossrefPubMedGoogle Scholar
• 88 Prince M, Thomas S, James O, Hudson M. Reduction in incidence of severe paracetamol poisoning.  Lancet . 2000;  355 2047-2048
  CrossrefPubMedGoogle Scholar
• 89 Turvill J, Burroughs A, Moore K. Change in occurrence of paracetamol overdose in UK after introduction of blister packs.  Lancet . 2000;  355 2048-2049
  CrossrefPubMedGoogle Scholar
• 90 Sheen C, Dillon J, Bateman D. et al . Paracetamol pack size restriction: the impact on paracetamol poisoning and over-the-counter supply of paracetamol, asprin and ibuprofen.  Pharmacoepidemiology and Drug Safety . 2002;  11 329-331
  CrossrefPubMedGoogle Scholar
• 91 Spooner J, Harvey J. Paracetamol overdose; Facts not misconceptions.  Pharmaceutical Journal . 1993;  252 706-707
  PubMedGoogle Scholar
• 92 Robinson D, Smith A, Johnston G. Severity of overdose after restriction of paracetamol availability: retrospective study.  BMJ . 2000;  321 926-927
  CrossrefPubMedGoogle Scholar
• 93 Sheen C, Dillon J, Bateman D. et al . The effect on toxicity on reducing the size of available paracetamol pack sizes.  Gut . 2001;  48(Suppl 1) A105
  PubMedGoogle Scholar
• 94 Poulin C. Prevention of paracetamol poisoning.  Lancet . 2000;  355 2009-2010
  CrossrefPubMedGoogle Scholar
• 95 Hill A. The environment and disease: association or causation?.  Proc R Soc Med . 1965;  295-300
  PubMedGoogle Scholar
• 96 Altman D. Practical Statistics for Medical Research.  London: Chapman and Hall; 1991
  Google Scholar
• 97 Bond G R, Hite L. Population-based incidence and outcome of acetaminophen poisoning by type of ingestion.  Acad Emerg Med . 1999;  6 1115-1120
  PubMedGoogle Scholar
• 98 Nourjah P, Willey M. Epidemiology of acetaminophen-related overdose. Department of Health and Human Services, Center for Drug Evaluation and Research, Food and Drug Administration, 2002. www.fda.gov/ohrms/dockets/ac/02/ briefing/3882b1.htm
  Google Scholar
• 99 Ahmad S. OPDRA safety review: review of acetaminophen poisoning exposures in Toxic Exposure Surveillance System (TESS). Department of Health and Human Services, Center for Drug Evaluation and Research, Food and Drug Administration, 2002. www.fda.gov/ohrms/dockets/ac/02 /briefing/3882b1.htm
  Google Scholar
• 100 Schiodt F, Atillasoy E, Shakil A. et al . Etiology and prognosis for 295 patients with acute liver failure in the US Liver Transplantation and Surgery .  1999;  5 29-34
  PubMedGoogle Scholar
• 101 Gyamlani G, Parikh C. Acetaminophen toxicity: suicidal versus accidental.  Critical Care . 2002;  6 155-169
  CrossrefPubMedGoogle Scholar
• 102 Prescott L. Therapeutic misadventure with paracetamol: fact or fiction?.  American Journal of Therapeutics . 2000;  7 99-114
  PubMedGoogle Scholar
• 103 Food and Drug Administration. September 2002.fdaadvisorycommittee.com/FDC/AdvisoryCommittee/Committees/Nonprescription+Drugs/091902 acetaminophen/091902 AcetaminophenR.htm#. 
  Google Scholar